CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, June 17th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...